EMA recommends approval for new oral GLP-1 medicine for weight management and type 2 diabetes
14:22 by Wendy WINN (DG SANTE, European Commission)The European Medicines Agency (EMA) has recommended granting a marketing authorisation in the European Union for Foundayo (orforglipron), an oral GLP-1 receptor agonist for weight management and treatment of type 2 diabetes in adults. For weight management, Foundayo is used alongside a healthy...